Form 4: Disc Medicine Executive Rahul Khara Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Rahul Khara, General Counsel of Disc Medicine, Inc., reports acquisition of common stock and stock options.
Summary
- On January 10, 2024, Rahul Khara, General Counsel of Disc Medicine, Inc., reported changes in beneficial ownership.
- Khara acquired 14,035 shares of common stock at $0.00.
- Khara also acquired options to purchase 21,050 shares of common stock at an exercise price of $63.90, vesting over time beginning January 10, 2025.
- Following these transactions, Khara directly owns 14,035 shares of common stock and options for 21,050 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of shares and options by an executive could be interpreted as a slightly positive signal, but it's not definitive.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The reported transactions provide shareholders with insight into the actions of a key company executive.
Key Dates
| Date | Description |
|---|---|
| 01/10/2024 | Date of the reported transactions: acquisition of common stock and stock options. |
| 01/10/2025 | 25% of the stock options vest and become exercisable. |
| 01/09/2034 | Expiration date of the stock options. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.